https://www.selleckchem.com/pr....oducts/jak-inhibitor
492678 and 0.593493, respectively, p value 10 ). Canal involvement was in line with the previous experiences. The results from this retrospective analysis unveiled the previously unexplored relation between reduction in cervical spine mobility and BPPV recurrence and treatment failure. The data from this study do not indicate the mechanisms by which this comorbidity might directly cause recurrent BPPV. However, they may suggest CROM to be evaluated, in association with other known risk factors for increased susceptibility t